SARIDON TRIPLE ACTION Paracetamol / Propyphenazone / Caffeine 250mg / 150mg / 50mg Tablet 1's
NONRXDRUG-DR-XY36639-1pc
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
For fast and effective relief of mild to severe headaches.
For the relief of pain such as headache, toothache, menstrual discomfort, postoperative and rheumatic pain.
For the relief of pain and fever associated with colds and "flu".
For the relief of pain such as headache, toothache, menstrual discomfort, postoperative and rheumatic pain.
For the relief of pain and fever associated with colds and "flu".
Dosage/Direction for Use
Single dose.
Adults: 1-2 tablets.
Adolescents aged 12-16 years: 1 tablet.
If necessary, up to three single doses may be taken within 24 hours.
The tablets should be taken with ample water or other fluid.
Should not be taken for more than one week or at doses higher than those recommended, except as directed by a doctor.
Missed Dose: No available information.
Adults: 1-2 tablets.
Adolescents aged 12-16 years: 1 tablet.
If necessary, up to three single doses may be taken within 24 hours.
The tablets should be taken with ample water or other fluid.
Should not be taken for more than one week or at doses higher than those recommended, except as directed by a doctor.
Missed Dose: No available information.
Overdosage
Signs and Symptoms of Overdose: Following overdose, symptoms of paracetamol poisoning often appear within 24-48 hours, but may be delayed beyond this time.
Symptoms: Poisoning is more likely to occur in the presence of alcohol. Liver damage (hepatocellular necrosis) and impairment of liver function may occur and may progress to hepatic coma. Clinical indications of liver damage may not manifest until 2-4 days following overdose.
Hypokalemia and metabolic acidosis (including lactic acidosis) may also develop in the setting of acute and/or chronic overdose.
There have been isolated reports of acute renal failure following paracetamol overdose.
Management of overdose: The cytotoxic effects can be lessened by intravenous administration of sulfhydryl compounds such as cysteamine or N-acetylcysteine, if possible within eight hours of ingestion of the overdose.
Symptoms: Poisoning is more likely to occur in the presence of alcohol. Liver damage (hepatocellular necrosis) and impairment of liver function may occur and may progress to hepatic coma. Clinical indications of liver damage may not manifest until 2-4 days following overdose.
Hypokalemia and metabolic acidosis (including lactic acidosis) may also develop in the setting of acute and/or chronic overdose.
There have been isolated reports of acute renal failure following paracetamol overdose.
Management of overdose: The cytotoxic effects can be lessened by intravenous administration of sulfhydryl compounds such as cysteamine or N-acetylcysteine, if possible within eight hours of ingestion of the overdose.
Administration
May be taken with or without food.
Contraindications
Saridon Triple Action should not be used if any of the following conditions is present: Allergy to pyrazolones or related compounds (hypersensitivity to phenazone, propyphenazone, aminophenazone, metamizole-containing products); Allergy to phenylbutazone-containing products; Known hypersensitivity to paracetamol, acetylsalicylic acid or proven allergy to caffeine; Inherited deficiency of glucose-6-phosphate dehydrogenase (evidenced by hemolytic anemia); Acute hepatic porphyria.
Special caution should be taken (lowering of the dosage and/or spacing out of the doses) in the following conditions: Impaired hepatic function (e.g. in cases of chronic alcohol abuse or hepatitis); Impaired renal function; Gilbert's syndrome (fluctuating benign jaundice secondary to glucuronyl-transferase deficiency); Hematopoietic dysfunction.
Saridon Triple Action should not be given to infants or children under 12 years of age.
Use in Pregnancy & Lactation: Category C.
It is recommended that Saridon Triple Action should not be used during pregnancy, particularly in the first trimester and in the final six weeks.
Saridon Triple Action should not be used by nursing women.
Special caution should be taken (lowering of the dosage and/or spacing out of the doses) in the following conditions: Impaired hepatic function (e.g. in cases of chronic alcohol abuse or hepatitis); Impaired renal function; Gilbert's syndrome (fluctuating benign jaundice secondary to glucuronyl-transferase deficiency); Hematopoietic dysfunction.
Saridon Triple Action should not be given to infants or children under 12 years of age.
Use in Pregnancy & Lactation: Category C.
It is recommended that Saridon Triple Action should not be used during pregnancy, particularly in the first trimester and in the final six weeks.
Saridon Triple Action should not be used by nursing women.
Special Precautions
Should not be taken regularly for a prolonged period, except as directed by a doctor.
Prolonged intake of paracetamol-containing analgesics resulting in high cumulative doses may in rare instances lead to analgesic nephropathy and largely irreversible renal insufficiency.
Very rare cases of serious skin reactions have been reported. In the event of skin reddening, rash, blisters or peeling, discontinue paracetamol use and seek medical attention immediately.
Continual use of analgesics for the treatment of headache may itself lead to chronic headaches.
Special caution for patients with asthma, chronic rhinitis or chronic urticaria, particularly those hypersensitive to other anti-inflammatory agents.
There have been isolated reports of asthma attacks and anaphylactic reaction associated with propyphenazone and paracetamol-containing preparations in susceptible individuals.
Consult a doctor: If symptoms persist, consult a doctor.
Ability to Drive: Unlikely to produce an impairment of driving performance or performance related to driving.
Prolonged intake of paracetamol-containing analgesics resulting in high cumulative doses may in rare instances lead to analgesic nephropathy and largely irreversible renal insufficiency.
Very rare cases of serious skin reactions have been reported. In the event of skin reddening, rash, blisters or peeling, discontinue paracetamol use and seek medical attention immediately.
Continual use of analgesics for the treatment of headache may itself lead to chronic headaches.
Special caution for patients with asthma, chronic rhinitis or chronic urticaria, particularly those hypersensitive to other anti-inflammatory agents.
There have been isolated reports of asthma attacks and anaphylactic reaction associated with propyphenazone and paracetamol-containing preparations in susceptible individuals.
Consult a doctor: If symptoms persist, consult a doctor.
Ability to Drive: Unlikely to produce an impairment of driving performance or performance related to driving.
Use In Pregnancy & Lactation
Category C.
It is recommended that Saridon Triple Action should not be used during pregnancy, particularly in the first trimester and in the final six weeks.
Saridon Triple Action should not be used by nursing women.
It is recommended that Saridon Triple Action should not be used during pregnancy, particularly in the first trimester and in the final six weeks.
Saridon Triple Action should not be used by nursing women.
Adverse Reactions
Allergic reactions such as skin rash and urticaria - occasional.
Hypersensitivity reactions with symptoms such as pruritus, erythema, urticaria, angioedema, dyspnea or asthma - very rare.
Isolated reports of anaphylactoid reactions or anaphylactic shocks.
Isolated cases of thrombocytopenia, leucopenia, agranulocytosis and pancytopenia associated with paracetamol and propyphenazone have been reported.
Hypersensitivity reactions with symptoms such as pruritus, erythema, urticaria, angioedema, dyspnea or asthma - very rare.
Isolated reports of anaphylactoid reactions or anaphylactic shocks.
Isolated cases of thrombocytopenia, leucopenia, agranulocytosis and pancytopenia associated with paracetamol and propyphenazone have been reported.
Drug Interactions
Hypnotics, Anti-epileptic drugs (phenobarbital, phenytoin, carbamazepine), Rifampicin, Propanthelin, Metoclopropamide, Chloramphenicol, Zidovudine, Barbiturates, Antihistaminics, Benzodiazepines, Oral contraceptives, Cimetidine, Disulfiram, Theophylline, Ephedrine, Smoking, Alcohol.
Caution For Usage
Instructions for Use/Handling: The tablets should be taken with ample water or other fluid.
Storage
Store at temperatures not exceeding 25°C.
MedsGo Class
Analgesics (Non-Opioid) & Antipyretics
Features
Brand
Saridon Triple Action
GTIN
4801962207997
Full Details
Dosage Strength
250 mg / 150 mg / 50 mg
Drug Ingredients
- Caffeine
- Paracetamol
- Propyphenazone
Drug Packaging
Tablet 1's
Generic Name
Caffeine / Paracetamol / Propyphenazone
Dosage Form
Tablet
Registration Number
DR-XY36639
Drug Classification
Over-The-Counter (OTC)
View all variations as list
| CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
|---|---|---|---|---|---|---|
|
|
NONRXDRUG-DR-XY36639-1pc
|
In stock
|
₱780 |
Please sign in so that we can notify you about a reply